Our Activities
In 2023 the Commons launched working groups to develop resources for various stakeholders to assist efforts in advancing the appropriate use of precision medicine in oncology. The Access Working Group, the Best Practices for Patient Education Resources Working Group, and the Implementation of Consistent Testing Terms Working Group met throughout 2023 to define needs and produce deliverables. Moving into 2024, the groups will be focusing on disseminating these materials across the oncology landscape.
-
Bianca Alvarez, ACCC
Deb Collyar, PAIR
Jessie Conta, PLUGS
David Davenport, PMC
Marcia Horn, ICAN
Christie Jett, Genetic Support Foundation
Rifeta Kajdic Hodzic, ACCC
Brandon Leonard, LUNGevity
Joan Levy, MRA
Sara Lindsey Patton, IASLC
Nikki Martin, LUNGevity
Leah McPherson, CSC
Jim Palma, Target Cancer Foundation
Chad Ramsey, OCRA
Beth Sandy, APSHO
Lisa Schlager, FORCE
Jilliane Sotelo, NSGC
Shannon Stasi, PLUGS
Pam Traxel, ACSCAN -
Tori Best, NBTS
Anne Mette Buhl, Clearity
Denisse Evans, Life Raft Group
Christie Jett, GSF
Erica Kuhn, Komen
Joan Levy, MRA
Stacie Lindsey, CCF
Nikki Martin, LUNGevity
Tracy Moore, OCRA
Martha Raymond, GICA
Rachel Saks, CSC
Jilliane Sotello, NSGC -
Christine Calafiore, CancerCare
Eric Konnick, CAP
Nikki Martin, LUNGevity
Beth Sandy, APSHO
Claire Saxton, CSC
Presentations
Understanding Barriers in Access to Biomarker Testing and Genetic Testing for Inherited Risk/Genetic Testing for Inherited Mutations (Genetic Testing)
Cancer Precision Medicine Commons work was presented at the Patient-Centered Laboratory Utilization Services (PLUGS) Annual Meeting, June 13-14, 2024. This poster summarizes surveys conducted among healthcare providers by the Commons to better define and understand access barriers for biomarker testing and genetic testing for inherited cancer risk.
